✦ LIBER ✦

Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine

✍ Scribed by U. Jeppesen; L. F. Gram; K. Vistisen; S. Loft; H. E. Poulsen; K. Brøsen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Relationship between fluvoxamine pharmac

✍ O. Spigset; K. Granberg; S. Hägg; Å. Norström; R. Dahlqvist 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 155 KB

Moclobemide, a substrate of CYP2C19 and

✍ Gram, Lars F.; Guentert, Theodor W.; Grange, Susan; Vistisen, Kirsten; BrÃ¸sen, 📂 Article 📅 1995 🏛 Nature Publishing Group 🌐 English ⚖ 817 KB

Polymorphism of CYP2D6, CYP2C19, CYP2C9

✍ Jónrit Halling; Maria S. Petersen; Per Damkier; Flemming Nielsen; Philippe Grand 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 290 KB

Genotypes for the cytochrome P450 enzyme

✍ L. Bathum; K. Andersen-Ranberg; J. Boldsen; K. Brøsen; B. Jeune 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 138 KB

Polymorphisms of drug-metabolizing enzym

✍ Elena A. Gaikovitch; Ingolf Cascorbi; Przemyslaw M. Mrozikiewicz; Jürgen Brockmö 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 233 KB

The relationship between clinical pharma

✍ Junichi Azuma; Tomoko Hasunuma; Masanori Kubo; Masaya Miyatake; Toshiko Koue; Ko 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 603 KB